ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.394,93
-0,11%
S&P 500
6.092,09
-0,44%
Dow Jones
44.360,60
-0,46%
Euro vs US Dollar
1,04955
0,77%
Bitcoin
105.178,02
1,17%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Recursion Pharmaceuticals Inc (RXRX) Börsenkurse

Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals Inc (RXRX)

NASDAQ
7,385
-0,145
( -1,93% )
Aktualisiert: 21:16:25
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
7,385
Gebot
7,38
Fragen
7,39
Volumen
21.394.322
7,36 Tagesbereich 8,26
5,61 52-Wochen-Bereich 15,74
Marktkapitalisierung
2,117B
Handelsende
7,53
Handelsbeginn
7,64
Letzte Trade
98
@
7.39
Letzter Handelszeitpunkt
21:16:32
Finanzvolumen
US$ 167.028.580
VWAP
7,8071
Durchschnittliches Volumen (3 Mio.)
13.753.586
Ausgegebene Aktien
286.640.833
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-6,54
Gewinn pro Aktie (EPS)
-1,14
Erlöse
44,58M
Nettogewinn
-328,07M

Über Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery... Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
www.recursion.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Recursion Pharmaceuticals Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker RXRX. The last closing price for Recursion Pharmaceuticals was US$7,53. Over the last year, Recursion Pharmaceuticals shares have traded in a share price range of US$ 5,61 to US$ 15,74.

Recursion Pharmaceuticals currently has 286.640.833 shares in issue. The market capitalisation of Recursion Pharmaceuticals is US$2,16 billion. Recursion Pharmaceuticals has a price to earnings ratio (PE ratio) of -6.54.

Option-Flow Recursion Pharmaceuticals (RXRX)

Vollständigen Option-Flow anzeigen

Gesamtfluss

Bullisch

Nettoprämie

887k

Calls / Puts

600,00%

Käuf. / Verkä.

188,89%

OTM / ITM

40,00%

Sweeps

0,00%

RXRX Neueste Nachrichten

Weitere Nachrichten

Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028

Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028 PR Newswire VANCOUVER, BC, Jan. 17, 2025 USA News Group News Commentary  Issued on behalf of Avant Technologies...

17 Januar 2025
PR Newswire (US)

Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028

Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028 PR Newswire VANCOUVER, BC, Jan. 17, 2025 USA News Group News Commentary  Issued on behalf of Avant Technologies...

17 Januar 2025
PR Newswire (US)

Form 144 - Report of proposed sale of securities

17 Januar 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

15 Januar 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

14 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

13 Januar 2025
Edgar (US Regulatory)

Form 8-K - Current report

13 Januar 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

10 Januar 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

08 Januar 2025
Edgar (US Regulatory)

Recursion Announces Two Key Investigational Oncology Drugs Advancing to Clinical Trials, Targeting High Unmet Needs in Hematologic Malignancies, Small-Cell Lung Cancer, & More

REC-3565 is a potential best-in-class MALT1 inhibitor for multiple hematology indications, designed to reduce the risk of hyperbilirubinemia, a common side effect of other MALT1 inhibitors...

07 Januar 2025
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.82512.57621951226.568.266.48184179757.17185755CS
4-0.215-2.828947368427.68.666.2153458917.10801618CS
121.02516.11635220136.369.555.61137535867.00383322CS
26-0.965-11.55688622758.359.555.6186188856.93015185CS
52-3.455-31.872693726910.8415.745.6172600498.16054529CS
156-3.765-33.766816143511.1516.7454.5440865658.70921512CS
260-22.615-75.38333333333042.814.5434270289.42072149CS

RXRX - Frequently Asked Questions (FAQ)

What is the current Recursion Pharmaceuticals share price?
The current share price of Recursion Pharmaceuticals is US$ 7,385
How many Recursion Pharmaceuticals shares are in issue?
Recursion Pharmaceuticals has 286.640.833 shares in issue
What is the market cap of Recursion Pharmaceuticals?
The market capitalisation of Recursion Pharmaceuticals is USD 2,16B
What is the 1 year trading range for Recursion Pharmaceuticals share price?
Recursion Pharmaceuticals has traded in the range of US$ 5,61 to US$ 15,74 during the past year
What is the PE ratio of Recursion Pharmaceuticals?
The price to earnings ratio of Recursion Pharmaceuticals is -6,54
What is the cash to sales ratio of Recursion Pharmaceuticals?
The cash to sales ratio of Recursion Pharmaceuticals is 48,17
What is the reporting currency for Recursion Pharmaceuticals?
Recursion Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Recursion Pharmaceuticals?
The latest annual turnover of Recursion Pharmaceuticals is USD 44,58M
What is the latest annual profit for Recursion Pharmaceuticals?
The latest annual profit of Recursion Pharmaceuticals is USD -328,07M
What is the registered address of Recursion Pharmaceuticals?
The registered address for Recursion Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Recursion Pharmaceuticals website address?
The website address for Recursion Pharmaceuticals is www.recursion.com
Which industry sector does Recursion Pharmaceuticals operate in?
Recursion Pharmaceuticals operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
NVNINVNI Group Ltd
US$ 4,80
(222,15%)
349,38M
EVAXEvaxion Biotech AS
US$ 6,274
(72,36%)
53,48M
ELABPMGC Holdings Inc
US$ 2,9895
(50,98%)
73,39M
NEUPNeuphoria Therapeutics Inc
US$ 5,09
(45,85%)
24,46M
PCLAPicoCELA Inc
US$ 4,30
(39,61%)
3,64M
GODNUGolden Star Acquisition Corporation
US$ 3,60
(-72,01%)
13,42k
GODNGolden Star Acquisition Corporation
US$ 2,9901
(-64,97%)
395,94k
NXTTNext Technology Holding Inc
US$ 1,3299
(-56,25%)
2,25M
SGLYSingularity Future Technology Ltd
US$ 1,63
(-38,26%)
845,85k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90,11
(-38,07%)
8
ACONAclarion Inc
US$ 0,0566
(31,02%)
735,5M
NVNINVNI Group Ltd
US$ 4,8105
(222,85%)
349,42M
GOEVCanoo Inc
US$ 0,432
(30,91%)
269,75M
RIMEAlgorhythm Holdings Inc
US$ 0,0368
(7,92%)
253,25M
RGTIRigetti Computing Inc
US$ 13,29
(-1,34%)
196,93M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
RXRX
Recursion Pharmaceuticals
BIT
1FSLR
First Solar
COIN
MZGUSD
Mooziecore MZI GOLD
BIT
UC4VDP
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten